These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15891701)

  • 1. Device trials in heart failure: a focused summary.
    Hedrich O; Weinstock J; Link M; Homoud M; Estes M
    Rev Cardiovasc Med; 2005; 6 Suppl 2():S21-31. PubMed ID: 15891701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias.
    Chapa DW; Lee HJ; Kao CW; Friedmann E; Thomas SA; Anderson J; Bardy GH
    Am J Crit Care; 2008 Sep; 17(5):443-52; quiz 453. PubMed ID: 18776000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable devices for management of chronic heart failure: defibrillators and biventricular pacing therapy.
    Pires LA
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):69-74. PubMed ID: 16547436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ongoing trials of cardiac resynchronisation.
    Cleland JG; Ghosh J; Khan N; Hurren S; Kaye G
    Minerva Cardioangiol; 2003 Apr; 51(2):197-207. PubMed ID: 12783075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac resynchronization therapy in heart failure patients: an update.
    Jeevanantham V; Daubert JP; Zareba W
    Cardiol J; 2009; 16(3):197-209. PubMed ID: 19437393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?
    Turley AJ; Raja SG; Salhiyyah K; Nagarajan K
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].
    Cleland JG; Daubert JC; Erdmann E; Freemantle N; Gras D; Kappenberger L; Tavazzi L
    Eur Heart J; 2006 Aug; 27(16):1928-32. PubMed ID: 16782715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials.
    Pires LA; Abraham WT; Young JB; Johnson KM;
    Am Heart J; 2006 Apr; 151(4):837-43. PubMed ID: 16569543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac resynchronisation therapy: what a hospital practitioner needs to know?
    Albouaini K; Alkarmi A; Wright DJ
    Postgrad Med J; 2010 Jan; 86(1011):12-7; quiz 16. PubMed ID: 20065336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival in cardiac resynchronization therapy. What do we know?
    Préda I
    Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():57-9. PubMed ID: 17584682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is implantable defibrillator indicated in all patients on cardiac resynchronization therapy?
    Pieragnoli P; Ricciardi G; Colella A; Musilli N; Porciani MC; Giaccardi M; Padeletti L; Michelucci A
    Minerva Cardioangiol; 2006 Dec; 54(6):735-41. PubMed ID: 17167385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biventricular pacing and defibrillator use in chronic heart failure.
    Cesario DA; Turner JW; Dec GW
    Cardiol Clin; 2007 Nov; 25(4):595-603; vii. PubMed ID: 18063163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of left ventricular lead location on outcomes in the COMPANION study.
    Saxon LA; Olshansky B; Volosin K; Steinberg JS; Lee BK; Tomassoni G; Guarnieri T; Rao A; Yong P; Galle E; Leigh J; Ecklund F; Bristow MR
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):764-8. PubMed ID: 19298563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac resynchronization therapy for treatment of heart failure in the elderly.
    Kron J; Conti JB
    Clin Geriatr Med; 2007 Feb; 23(1):193-203. PubMed ID: 17126762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.
    Yao G; Freemantle N; Calvert MJ; Bryan S; Daubert JC; Cleland JG
    Eur Heart J; 2007 Jan; 28(1):42-51. PubMed ID: 17110403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Device based treatment of heart failure.
    Patwala AY; Wright DJ
    Postgrad Med J; 2005 May; 81(955):286-91. PubMed ID: 15879039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
    Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac resynchronisation therapy for heart failure.
    Behan MW; Rinaldi CA
    Int J Clin Pract; 2006 Sep; 60(9):1107-14. PubMed ID: 16939553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of elderly heart failure recipients of ICD and CRT.
    Grimm W
    Int J Cardiol; 2008 Apr; 125(2):154-60. PubMed ID: 17976843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.